Search by Drug Name or NDC
NDC 23155-0240-42 Metoclopramide 5 mg/mL Details
Metoclopramide 5 mg/mL
Metoclopramide is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is METOCLOPRAMIDE HYDROCHLORIDE.
Product Information
| NDC | 23155-0240 |
|---|---|
| Product ID | 23155-240_a9c0f2bb-0052-4edc-a04d-1c4f599118bb |
| Associated GPIs | 52300020102005 |
| GCN Sequence Number | 005229 |
| GCN Sequence Number Description | metoclopramide HCl VIAL 5 MG/ML INJECTION |
| HIC3 | J9A |
| HIC3 Description | INTESTINAL MOTILITY STIMULANTS |
| GCN | 20510 |
| HICL Sequence Number | 002148 |
| HICL Sequence Number Description | METOCLOPRAMIDE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Metoclopramide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Metoclopramide Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204756 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0240-42 (23155024042)
| NDC Package Code | 23155-240-42 |
|---|---|
| Billing NDC | 23155024042 |
| Package | 25 VIAL in 1 CARTON (23155-240-42) / 10 mL in 1 VIAL (23155-240-32) |
| Marketing Start Date | 2014-01-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |